Literature DB >> 35751573

Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease.

Priya Kumthekar1, Seema Nagpal2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35751573      PMCID： PMC9527512          DOI： 10.1093/neuonc/noac142

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  8 in total

1.  Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma.

Authors:  Rachael A Vaubel; Shulan Tian; Dioval Remonde; Mark A Schroeder; Ann C Mladek; Gaspar J Kitange; Alissa Caron; Thomas M Kollmeyer; Rebecca Grove; Sen Peng; Brett L Carlson; Daniel J Ma; Gobinda Sarkar; Lisa Evers; Paul A Decker; Huihuang Yan; Harshil D Dhruv; Michael E Berens; Qianghu Wang; Bianca M Marin; Eric W Klee; Andrea Califano; Daniel H LaChance; Jeanette E Eckel-Passow; Roel G Verhaak; Erik P Sulman; Terry C Burns; Fredrick B Meyer; Brian P O'Neill; Nhan L Tran; Caterina Giannini; Robert B Jenkins; Ian F Parney; Jann N Sarkaria
Journal:  Clin Cancer Res       Date:  2019-12-18       Impact factor: 12.531

2.  Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.

Authors:  Inna Smalley; Vincent Law; Clayton Wyatt; Brittany Evernden; Bin Fang; John M Koomen; Eric A Welsh; Robert J B Macaulay; Peter A Forsyth; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

3.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

Review 4.  Leptomeningeal disease.

Authors:  Morris D Groves
Journal:  Neurosurg Clin N Am       Date:  2011-01       Impact factor: 2.509

5.  Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

Authors:  Adrienne Boire; Yilong Zou; Jason Shieh; Danilo G Macalinao; Elena Pentsova; Joan Massagué
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

Review 6.  Leptomeningeal disease: current diagnostic and therapeutic strategies.

Authors:  Gautam Nayar; Tiffany Ejikeme; Pakawat Chongsathidkiet; Aladine A Elsamadicy; Kimberly L Blackwell; Jeffrey M Clarke; Shivanand P Lad; Peter E Fecci
Journal:  Oncotarget       Date:  2017-08-16

7.  A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.

Authors:  Vincent Law; Zhihua Chen; Francesca Vena; Inna Smalley; Robert Macaulay; Brittany R Evernden; Nam Tran; Yolanda Pina; John Puskas; Gisela Caceres; Simon Bayle; Joseph Johnson; James K C Liu; Arnold Etame; Michael Vogelbaum; Paulo Rodriguez; Derek Duckett; Brian Czerniecki; Ann Chen; Keiran S M Smalley; Peter A Forsyth
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

Review 8.  Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines.

Authors:  Manuel Valiente; Amanda E D Van Swearingen; Carey K Anders; Amos Bairoch; Adrienne Boire; Paula D Bos; Diana M Cittelly; Neta Erez; Gino B Ferraro; Dai Fukumura; Brunilde Gril; Meenhard Herlyn; Sheri L Holmen; Rakesh K Jain; Johanna A Joyce; Mihaela Lorger; Joan Massague; Josh Neman; Nicola R Sibson; Patricia S Steeg; Frits Thorsen; Leonie S Young; Damir Varešlija; Adina Vultur; Frances Weis-Garcia; Frank Winkler
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.